HC Wainwright & Co. Maintains Buy on Alector, Raises Price Target to $8

10/14/2026
Impact: 70
Healthcare

HC Wainwright & Co. analyst Andrew S. Fein has maintained a 'Buy' rating on Alector (NASDAQ: ALEC) and increased the price target from $5 to $8. This adjustment reflects a positive outlook for the company's stock performance.

AI summary, not financial advice

Share: